Article
Development and validation of the Elecsys Anti-SARS-CoV-2 immunoassay as a highly specific…
· 2020 · Muench P, Jochum S, Wenderoth V, Ofenloch-Haehnle B, Hombach M, Strobl M, Sadlowski H, Sachse C, Riedel A.
Key facts
| Title | Development and validation of the Elecsys Anti-SARS-CoV-2 immunoassay as a highly specific tool for determining past exposure to SARS-CoV-2 |
|---|---|
| First author | Muench P, Jochum S, Wenderoth V, Ofenloch-Haehnle B, Hombach M, Strobl M, Sadlowski H, Sachse C, Riedel A. |
| Published | Jun 19, 2020 |
| DOI | 10.1101/2020.06.16.20132803 |
| Devices mentioned | BK230839, BK230840, K000042, K000155, K000270, K000576, K001014, K001015, K001468, K001846, K001906, K002148 and 183 more |
| Product codes mentioned | CDD, CDP, CDX, CDZ, CEC, CEP, CEW, CFL, CFP, CFT, CGJ, CGN and 59 more |
At a glance
- 100–999 FDA submissions mentioned
- 10–99 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1